Report error Found 52 Enz. Inhib. hit(s) with all data for entry = 50041764
TargetCholecystokinin receptor type A(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataKi: 12.6nMAssay Description:Displacement of [125I]-CCK-8S from CCK1R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
TargetGastrin/cholecystokinin type B receptor(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataKi: 15.8nMAssay Description:Displacement of [125I]-CCK-8S from CCK2R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
TargetCholecystokinin receptor type A(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataKi: 25.1nMAssay Description:Displacement of [125I]-CCK-8S from CCK1R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
TargetCholecystokinin receptor type A(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataKi: 31.6nMAssay Description:Displacement of [125I]-CCK-8S from CCK1R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
TargetGastrin/cholecystokinin type B receptor(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataKi: 39.8nMAssay Description:Displacement of [125I]-CCK-8S from CCK2R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
TargetCholecystokinin receptor type A(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataKi: 50.1nMAssay Description:Displacement of [125I]-CCK-8S from CCK1R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
TargetCholecystokinin receptor type A(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataKi: 63.1nMAssay Description:Displacement of [125I]-CCK-8S from CCK1R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
TargetGastrin/cholecystokinin type B receptor(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataKi: 63.1nMAssay Description:Displacement of [125I]-CCK-8S from CCK2R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
TargetCholecystokinin receptor type A(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataKi: 79.4nMAssay Description:Displacement of [125I]-CCK-8S from CCK1R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
TargetCholecystokinin receptor type A(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataKi: 79.4nMAssay Description:Displacement of [125I]-CCK-8S from CCK1R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
TargetGastrin/cholecystokinin type B receptor(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataKi: 79.4nMAssay Description:Displacement of [125I]-CCK-8S from CCK2R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
TargetCholecystokinin receptor type A(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataKi: 79.4nMAssay Description:Displacement of [125I]-CCK-8S from CCK1R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
TargetCholecystokinin receptor type A(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataKi: 79.4nMAssay Description:Displacement of [125I]-CCK-8S from CCK1R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
TargetCholecystokinin receptor type A(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataKi: 100nMAssay Description:Displacement of [125I]-CCK-8S from CCK1R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
TargetCholecystokinin receptor type A(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataKi: 158nMAssay Description:Displacement of [125I]-CCK-8S from CCK1R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
TargetGastrin/cholecystokinin type B receptor(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataKi: 158nMAssay Description:Displacement of [125I]-CCK-8S from CCK2R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
TargetGastrin/cholecystokinin type B receptor(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataKi: 158nMAssay Description:Displacement of [125I]-CCK-8S from CCK2R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
TargetCholecystokinin receptor type A(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataKi: 200nMAssay Description:Displacement of [125I]-CCK-8S from CCK1R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
TargetCholecystokinin receptor type A(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataKi: 200nMAssay Description:Displacement of [125I]-CCK-8S from CCK1R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
TargetCholecystokinin receptor type A(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataKi: 251nMAssay Description:Displacement of [125I]-CCK-8S from CCK1R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
TargetCholecystokinin receptor type A(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataKi: 316nMAssay Description:Displacement of [125I]-CCK-8S from CCK1R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
TargetGastrin/cholecystokinin type B receptor(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataKi: 316nMAssay Description:Displacement of [125I]-CCK-8S from CCK2R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
TargetCholecystokinin receptor type A(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataKi: 398nMAssay Description:Displacement of [125I]-CCK-8S from CCK1R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
TargetGastrin/cholecystokinin type B receptor(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataKi: 398nMAssay Description:Displacement of [125I]-CCK-8S from CCK2R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
TargetCholecystokinin receptor type A(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataKi: 501nMAssay Description:Displacement of [125I]-CCK-8S from CCK1R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
TargetGastrin/cholecystokinin type B receptor(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataKi: 501nMAssay Description:Displacement of [125I]-CCK-8S from CCK2R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
TargetGastrin/cholecystokinin type B receptor(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataKi: 501nMAssay Description:Displacement of [125I]-CCK-8S from CCK2R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
TargetGastrin/cholecystokinin type B receptor(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataKi: 501nMAssay Description:Displacement of [125I]-CCK-8S from CCK2R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
TargetGastrin/cholecystokinin type B receptor(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataKi: 631nMAssay Description:Displacement of [125I]-CCK-8S from CCK2R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
TargetGastrin/cholecystokinin type B receptor(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataKi: 631nMAssay Description:Displacement of [125I]-CCK-8S from CCK2R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
TargetGastrin/cholecystokinin type B receptor(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataKi: 631nMAssay Description:Displacement of [125I]-CCK-8S from CCK2R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
TargetCholecystokinin receptor type A(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataKi: 1.00E+3nMAssay Description:Displacement of [125I]-CCK-8S from CCK1R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
TargetGastrin/cholecystokinin type B receptor(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataKi: 1.00E+3nMAssay Description:Displacement of [125I]-CCK-8S from CCK2R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
TargetGastrin/cholecystokinin type B receptor(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataKi: 1.00E+3nMAssay Description:Displacement of [125I]-CCK-8S from CCK2R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
TargetGastrin/cholecystokinin type B receptor(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataKi: 1.26E+3nMAssay Description:Displacement of [125I]-CCK-8S from CCK2R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
TargetGastrin/cholecystokinin type B receptor(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataKi: 1.26E+3nMAssay Description:Displacement of [125I]-CCK-8S from CCK2R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
TargetGastrin/cholecystokinin type B receptor(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataKi: 1.58E+3nMAssay Description:Displacement of [125I]-CCK-8S from CCK2R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
TargetGastrin/cholecystokinin type B receptor(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataKi: 1.58E+3nMAssay Description:Displacement of [125I]-CCK-8S from CCK2R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
TargetCholecystokinin receptor type A(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataKi: 2.00E+3nMAssay Description:Displacement of [125I]-CCK-8S from CCK1R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
TargetCholecystokinin receptor type A(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataKi: 2.00E+3nMAssay Description:Displacement of [125I]-CCK-8S from CCK1R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
TargetGastrin/cholecystokinin type B receptor(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataKi: 2.51E+3nMAssay Description:Displacement of [125I]-CCK-8S from CCK2R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
TargetCholecystokinin receptor type A(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataKi: 3.16E+3nMAssay Description:Displacement of [125I]-CCK-8S from CCK1R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
TargetCholecystokinin receptor type A(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataKi: 3.98E+3nMAssay Description:Displacement of [125I]-CCK-8S from CCK1R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
TargetCholecystokinin receptor type A(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataKi: 3.98E+3nMAssay Description:Displacement of [125I]-CCK-8S from CCK1R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
TargetCholecystokinin receptor type A(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataKi: 3.98E+3nMAssay Description:Displacement of [125I]-CCK-8S from CCK1R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
TargetGastrin/cholecystokinin type B receptor(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataKi: 6.31E+3nMAssay Description:Displacement of [125I]-CCK-8S from CCK2R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
TargetGastrin/cholecystokinin type B receptor(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataKi: 7.94E+3nMAssay Description:Displacement of [125I]-CCK-8S from CCK2R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
TargetGastrin/cholecystokinin type B receptor(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataKi: 7.94E+3nMAssay Description:Displacement of [125I]-CCK-8S from CCK2R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
TargetCholecystokinin receptor type A(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataKi: >1.00E+4nMAssay Description:Displacement of [125I]-CCK-8S from CCK1R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
TargetGastrin/cholecystokinin type B receptor(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataKi: >1.00E+4nMAssay Description:Displacement of [125I]-CCK-8S from CCK2R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
























